title: Development of delayed cardiac tamponade 55 days after catheter ablation for atrial fibrillation with a new oral anticoagulant.
authors.affiliation: Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, 2-34-10 Ebisu, Shibuya-ku, Tokyo, Japan, take1124@hotmail.co.jp.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kitamura
authors.forename: Seiji
authors.initials: S
authors.lastname: Fukamizu
authors.forename: Harumizu
authors.initials: H
authors.lastname: Sakurada
authors.forename: Masayasu
authors.initials: M
authors.lastname: Hiraoka
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D002305:Cardiac Tamponade / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D017115:Catheter Ablation / Q000009:adverse effects* / Q000379:methods; D015150:Echocardiography, Doppler / Q000379:methods; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009025:Morpholines / Q000009:adverse effects / Q000627:therapeutic use; D020519:Pericardiocentesis / Q000379:methods; D010996:Pleural Effusion / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy; D011183:Postoperative Complications / Q000175:diagnosis / Q000628:therapy; D035583:Rare Diseases; D000069552:Rivaroxaban; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban